Important to the trial, none of those enrolled were actively seeking treatment for their drinking or attempting to reduce their drinking
Approach Phase 2b trial arm Duration 24 weeks Review Point Week 12 and 24 Notes METAOD006 (OPTIONS) used 24 weeks at oral doses 0.25, 0.5, or 1 mg/day in 502 obese adults
Zonulin is a protein that plays a crucial role in the regulation of intestinal permeability, also known as the "leaky gut" phenomenon
Cell 167:843857.e814 Ethics declarations Funding This work was supported in part by Deutsches Zentrum fr Diabetesforschung (DZD), Alexander von Humboldt Foundation, Helmholtz Alliance ICEMED through the Initiative and Networking Fund of the Helmholtz Association, and the Helmholtz cross-program topic Metabolic Dysfunction
Most studies have a low risk of bias in selective outcome data ( Figures 2 , 3 )
Endometriosis: etiology, pathobiology, and therapeutic prospects